Common eczema treatment may provide little benefit, study finds

Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged inAllNewsSportCultureLifestyleA recent study indicates that prescribing antihistamines for eczema symptoms offers no significant benefit and may "probably increase harms". Experts have welcomed these findings, which address "longstanding uncertainty" regarding the medications' role, and are now urging for updated medical guidance. Despite existing recommendations from the National Institute for Health and Care Excellence (NICE) against routine use, approximately one in five eczema patients in the UK currently use antihistamines. A review of 47 trials involving over 6,200 patients found antihistamines led to a "clinically unimportant reduction" in eczema severity and itchiness, and may not reduce sleep disturbance or flare-ups. The study also highlighted that first-generation antihistamines can increase cognitive impairment and potentially lead to patients discontinuing treatment due to side effects. In fullCommon eczema treatment could actually make it worse, study suggestsMore bulletinsThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in

Raccontata damedpagetoday.comindependent.co.ukmirror.co.uk